CalciMedica, Inc. SEC filings CALC

CalciMedica, Inc. has 531 filings in SEC EDGAR's recent list, going back to Nov 8, 2011. Its latest annual report, Form ARS, was filed on Jul 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 16, 2026 (officer or director change). The company's fiscal year ends on December 31.

CalciMedica, Inc. SEC filings
Form Description Filed Period
DEF 14A Proxy statement Jul 23, 2026 Aug 19, 2026
PRE 14A Preliminary proxy statement Jul 13, 2026 Aug 19, 2026
DEFA14A Additional proxy material Jun 9, 2025 —
DEFA14A Additional proxy material Apr 30, 2025 —
DEF 14A Proxy statement Apr 29, 2025 Jun 24, 2025
DEFA14A Additional proxy material Jul 16, 2024 —
DEF 14A Proxy statement Jul 16, 2024 Aug 27, 2024
DEFA14A Additional proxy material Jun 28, 2023 —
DEF 14A Proxy statement Jun 28, 2023 Aug 9, 2023
DEFA14A Additional proxy material Mar 3, 2023 —
DEFA14A Additional proxy material Feb 16, 2023 —
DEFM14A Filing Feb 9, 2023 —
PREM14A Filing Dec 14, 2022 Dec 14, 2022
DEFA14A Additional proxy material Nov 22, 2022 —
DEFA14A Additional proxy material Nov 22, 2022 —
DEFA14A Additional proxy material May 9, 2022 —
DEF 14A Proxy statement Apr 22, 2022 Jun 2, 2022
DEFA14A Additional proxy material Apr 23, 2021 —
DEF 14A Proxy statement Apr 23, 2021 Jun 2, 2021

Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CALC (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
La Jolla, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1534133
Former names
CalciMedica, Inc. /DE/ (until Mar 22, 2023); GRAYBUG VISION, INC. (until Mar 15, 2023); GRAYBUG, Inc. (until May 13, 2016); GRAYBUG LLC (until Oct 7, 2014)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.